Smartphone Blood Pressure Measurement to Screen for Hypertension
Optiscreen
Assessing the Feasibility of Classifying People Using a Machine-learning Approached Based on Features Derived From Smartphone Video Data Recorded at the Person's Fingertip
1 other identifier
observational
100
1 country
2
Brief Summary
The goal of this observational study is to assess the feasibility of classifying people whose blood pressures are within hypertensive range using a machine-learning approach based on features derived from smartphone video data recorded at the patient's fingertips. The main question\[s\] it aims to answer are: Is a smartphone a reliable device for high blood pressure screening ? Is a smartphone a reliable device for blood pressure monitoring ? Participants will record their blood pressure with a smartphone at their fingertips and with an approved cuff device, 3 times in the morning and 3 times in the evening for 7 days. There will be two groups, a volunteer presumed healthy, and a volunteer addressed for a Home Blood pressure monitoring with the diagnosis of hypertension suspected. Researchers will compare the two groups to see if the smartphone can be reliable in terms of diagnosis and monitoring of the blood pressure comparing to a standard cuff device.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2024
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 27, 2024
CompletedFirst Posted
Study publicly available on registry
August 29, 2024
CompletedStudy Start
First participant enrolled
September 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2026
March 27, 2026
March 1, 2026
2.3 years
August 27, 2024
March 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Measurement of blood pressure by a smartphone
Reliability of blood pressure measure by smartphone to discriminate values within hypertension range compared to standard cuff device
7 days
Study Arms (2)
Volunteer presumed healthy
People presumed healthy undergoing blood pressure measurement with a standard cuff device and with a Smartphone
Volunteer suspected of arterial hypertension
People addressed for a suspected diagnosis of arterial hypertension undergoing a home blood pressure monitoring and measurements with a smartphone
Interventions
Blood pressure measurement using a standard cuff device and a smartphone
Eligibility Criteria
For this study, the aim is to reach balanced classes, with at least 40% of non-hypertensive patients and 40% of hypertensive patients. In order to approach such distributions, both healthy volunteers and patients suspected of hypertension visiting the CHUV Hypertensive Unit for diagnosis confirmation will be recruited.
You may qualify if:
- Informed consent as documented by signature
- Men or women older than 18 years old
- Good understanding of written and oral speaking used at the center where the study will be carried out
You may not qualify if:
- Patients that cannot sign informed consent
- Patients in emergency situation, are not legally competent, cannot understand the situation or are vulnerable
- Unable to participate due to pain or stress \[12\]
- Known or suspected non-compliance (e.g. drug or alcohol abuse, language problems, psychological disorders, dementia)
- Patients older than 80 years old \[4\] \[13\]
- Known pregnancy
- Known unstable cardiac condition (myocardial infarction \< 1 week, decompensated heart failure, pulmonary embolism)
- End-stage renal disease (GFR \< 15/min/1.73m2 and/or dialysis) \[4\] \[14\] \[15\] \[16\]
- Diabetes mellitus \[15\] \[8\]
- Known (or assessed by recording heart rate and using pulse palpation, as recommended in ESC/ESH guidelines \[1\]) cardiac arrhythmia (atrial fibrillation, numerous extrasystoles and important bradycardia/bradyarrhythmia, bigeminy, trigeminy, isolated VPB) \[4\] \[1\] \[7\] \[15\] \[17\]
- SBP or DBP difference between two arms \>10 mmHg \[8\] \[18\]
- Patient with finger lesions that would alter the correct capture of signals by the mobile phone.
- Known mobile phone contact dermatitis (caused by metal allergens, notably nickel and chromium
- Incapacity of properly using the smartphone (i.e. incapacity of obtaining a recording with sufficient signal quality after the dedicated training)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University Hospital Lausanne
Lausanne, Canton of Vaud, 1011, Switzerland
University Hospital Lausanne CHUV
Lausanne, 1011, Switzerland
Study Officials
- PRINCIPAL INVESTIGATOR
Patrick Schoettker, PhD
Centre Hospitalier Universitaire Vaudois
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 27, 2024
First Posted
August 29, 2024
Study Start
September 1, 2024
Primary Completion (Estimated)
December 30, 2026
Study Completion (Estimated)
December 30, 2026
Last Updated
March 27, 2026
Record last verified: 2026-03